mefloquine has been researched along with zithromax in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Davis, TM | 1 |
| Kain, KC; Keystone, JS; Shanks, GD | 1 |
| Buchachart, K; Chalermrut, K; Charusabha, C; Duangdee, C; Haoharn, O; Krudsood, S; Looareesuwan, S; Treeprasertsuk, S | 1 |
| Davis, TM; Hackett, SL; Ilett, KF; Karunajeewa, HA; Lautu, D; Mueller, I; Siba, P; Tavul, L; Wong, RP | 1 |
| Capan, M; Makristathis, A; Mombo-Ngoma, G; Ramharter, M | 1 |
| Terlouw, DJ; van Eijk, AM | 1 |
| Chandramohan, D; Chico, RM | 1 |
| Chandra, R; Dieng, Y; Djimdé, AA; Dunne, MW; Kain, KC; Mugyenyi, P; Mulenga, M; Oduro, AR; Ogutu, B; Robbins, J; Sagara, I; Sarkar, S; Sie, A; Tiono, AB; Wasunna, M | 1 |
| Agarwal, P; Anvikar, AR; Pillai, CR; Srivastava, K | 1 |
4 review(s) available for mefloquine and zithromax
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
Topics: Animals; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Resistance; Health Planning Guidelines; Humans; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Primaquine; Proguanil | 2001 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
Topics: Adult; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antimalarials; Azithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Public Health; Pyrimethamine; Sexually Transmitted Diseases; Sulfadoxine; Treatment Outcome | 2011 |
2 trial(s) available for mefloquine and zithromax
| Article | Year |
|---|---|
A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Azithromycin; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Statistics, Nonparametric; Thailand | 2002 |
Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Azithromycin; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome; Uganda; Young Adult; Zambia | 2014 |
5 other study(ies) available for mefloquine and zithromax
| Article | Year |
|---|---|
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Adverse effects of antimalarial prophylactic drugs: an important consideration in the risk-benefit equation.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Atovaquone; Azithromycin; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthoquinones; Plasmodium falciparum; Plasmodium vivax; Primaquine; Proguanil; Pyrimethamine; Risk Assessment | 1998 |
In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea.
Topics: Amodiaquine; Antimalarials; Artemisinins; Azithromycin; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Infant; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Male; Mefloquine; Membrane Transport Proteins; Naphthoquinones; Plasmodium falciparum; Protozoan Proteins; Quinolines; Threshold Limit Values | 2010 |
Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin.
Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Bacterial Infections; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mefloquine; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2010 |
Topics: Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Atovaquone; Azithromycin; Chloroquine; Doxycycline; Ethanolamines; Fluorenes; Humans; India; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Quinolines | 2017 |